WP
QNRX

Woodline Partners’s Quoin Pharmaceuticals QNRX Stock Holding History

Woodline Partners’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$370K Sell
76,446
-3,136
-4% -$16.9K ﹤0.01% 985
2026
Q1 		$525K Hold
79,582
– – ﹤0.01% 957
2025
Q4 		$1.15M Buy
+79,582
New +$1.08M ﹤0.01% 832

Other funds holding QNRX

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Woodline Partners's QNRX Position: Q2 2026 in Review

Woodline Partners reduced its Quoin Pharmaceuticals (QNRX) stake by 3.9% in Q2 2026, selling an estimated $16.9K and leaving 76,446 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #985.

Woodline Partners first reported a position in QNRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.15M in Q4 2025. 20 funds tracked by Wall St. Rank hold QNRX as of Q2 2026.

  • Woodline Partners held 76,446 shares of Quoin Pharmaceuticals worth $370K as of Q2 2026.
  • Woodline Partners sold 3,136 Quoin Pharmaceuticals shares in Q2 2026, an estimated $16.9K.
  • Quoin Pharmaceuticals made up ﹤0.01% of Woodline Partners's portfolio in Q2 2026, its #985 holding.
  • Woodline Partners first reported a position in Quoin Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Woodline Partners's Quoin Pharmaceuticals position peaked at $1.15M in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.